Vanguard Group Inc Htg Molecular Diagnostics, Inc Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.62 - $1.89 $2,786 - $8,495	-4,495 Reduced 5.96%	70,922 $43,000
Q2 2022 Aug 12, 2022	SELL	$0.46 - $1.45 $78,360 - $247,006	-170,349 Reduced 69.31%	75,417 $78,000
Q4 2021 Feb 14, 2022	SELL	$3.23 - $5.97 $969 - $1,791	-300 Reduced 0.12%	245,766 $1.33 Million
Q3 2021 Nov 12, 2021	BUY	$5.01 - $6.8 $13,732 - $18,638	2,741 Added 1.13%	246,066 $1.41 Million
Q2 2021 Aug 13, 2021	BUY	$3.52 - $5.98 $856,504 - $1.46 Million	243,325 New	243,325 $1.41 Million

Ticker HTGM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 11,048,100
Market Cap $3.76M
Description
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-o...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.